Draegerwerk AG & Co KGaA (DRW3) Earns “Sell” Rating from DZ Bank

Draegerwerk AG & Co KGaA (ETR:DRW3)‘s stock had its “sell” rating reissued by research analysts at DZ Bank in a research note issued to investors on Tuesday.

Other equities analysts have also issued reports about the company. Nord/LB set a €92.00 ($113.58) target price on Draegerwerk AG & Co KGaA and gave the company a “buy” rating in a research report on Tuesday, March 20th. Warburg Research set a €81.50 ($100.62) target price on Draegerwerk AG & Co KGaA and gave the company a “neutral” rating in a research report on Monday, March 12th. Berenberg Bank set a €75.00 ($92.59) target price on Draegerwerk AG & Co KGaA and gave the company a “neutral” rating in a research report on Thursday, March 8th. HSBC set a €72.00 ($88.89) target price on Draegerwerk AG & Co KGaA and gave the company a “neutral” rating in a research report on Thursday, January 25th. Finally, Deutsche Bank set a €73.00 ($90.12) target price on Draegerwerk AG & Co KGaA and gave the company a “neutral” rating in a research report on Monday, January 22nd. Four research analysts have rated the stock with a sell rating and six have assigned a hold rating to the company. The company presently has an average rating of “Hold” and a consensus target price of €76.89 ($94.92).

How to Become a New Pot Stock Millionaire

Shares of DRW3 opened at €70.30 ($86.79) on Tuesday. Draegerwerk AG & Co KGaA has a 52-week low of €69.80 ($86.17) and a 52-week high of €107.00 ($132.10).

TRADEMARK VIOLATION NOTICE: “Draegerwerk AG & Co KGaA (DRW3) Earns “Sell” Rating from DZ Bank” was first posted by Ticker Report and is owned by of Ticker Report. If you are accessing this article on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright law. The legal version of this article can be read at www.tickerreport.com/banking-finance/3364458/draegerwerk-ag-co-kgaa-drw3-earns-sell-rating-from-dz-bank.html.

Draegerwerk AG & Co KGaA Company Profile

Dragerwerk AG & Co KGaA develops equipment and solutions in the fields of medical and safety technology in Europe, Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including perioperative care, neonatal care, emergency care, critical care, and perinatal care.

Analyst Recommendations for Draegerwerk AG & Co KGaA (ETR:DRW3)

Leave a Reply

Your email address will not be published. Required fields are marked *